Cartagenia Raises $2.9M in Private Financing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cartagenia, a Leuven, Belgium-based firm developing software and database systems for genetic analyses, today said that it has received a capital injection of €2.2 million ($2.9 million).

The company said that it would use the funds to further develop its market presence, open an office in the US, and invest in a new product line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.